When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Each exposure has provided him with a different perspective on quality management and regulatory compliance from several pharmaceutical companies. Q 1: What attracted you to pharmaceutical quality ...